BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX has expanded the application of its Anchored Multiplex PCR (AMP™) technology to include DNA variant detection with the VariantPlex™ Solid Tumor Panel. The VariantPlex Solid Tumor panel is a targeted next-generation sequencing (NGS)-based assay to detect somatic variants in 67 cancer-associated genes. The addition of the VariantPlex product line combined with Archer’s existing FusionPlex™ line of RNA-based fusion detection assays demonstrates the company’s commitment to bringing translational sequencing applications to the broader sequencing community.
Help employers find you! Check out all the jobs and post your resume.
